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      ABSTRACT
INTRODUCTION
           The rheumatoid arthritis (RA) is a chronic sys-
temic disease, characterized by inflammatory incidents 
in the sinovyal membranes and articular structures. Fi-
brinoid degeneration of collagen fibers in mesenchymas 
tissues, atrophy and rarefaction of osseous structures 
[19] take place. Autoimmune mechanisms have been 
listed as indicative of this pathology that affects the 
joints of the hands, fists, elbows, shoulders, feet, ankles 
and knees, and can acquire a systemic character, devel-
oping extra-articular, cardiac, pulmonary, vascular and 
ophthalmologic manifestations [30]. It is believed that 
1% of the population in Brazil is affected by this pa-
thology, congregating an increasing universe of carriers 
of some articular deformity, generating incapacities at 
a predominantly professionally active age (between 30 
and 50 years old) [6]. Generally, rheumatoid arthritis 
appears after the age of 30, occurring three times more 
in women than in men [1]. Despite the high occurrence, 
the RA etiology remains unknown and it is believed to 
be related to genetic factors [8, 18] that determine the 
individuals whose immunological system is susceptible 
to being attacked by the disease. Genes related with RA 
are not simply or directly inherited. Infectious, chemi-
cal or mechanical hormones or environmental factors 
can contribute to the development of the pathology in 
susceptible, genetically determined people [7, 20, 23-
25]. The disarrangement of the immune system that oc-
curs in RA is extremely complex. Autoantigens cause 
The models of experimental arthritis become important in the inquiry of different therapeutical 
alternatives and briefing of articulate pathogenesis. The possibility of measuring the injury of 
the articular cartilage makes the experimental model relevantly important, as well as the sys-
temic biological effects that involve the different therapeutics: The radiological and histologi-
cal aspects of the cartilage were researched in the model of Zynoman-induced arthritis in Rat-
tus novergicus. Rats were submitted to the intra-articular injection (1.0ml) and sacrificed at 
different times, under anesthesia. The knee joints were surgically removed and processed for 
coloring in hematoxylin eosin (H&E). The radiographic analyses were carried out through im-
ages obtained with dental periapical film. The animals presented serious and gradual synovi-
tis associated to the injury of the cartilage that was evaluated up to 14 days after the stimula-
tion injection. The arthritis model by Zymosan allows the study of the inflammatory alteration 
of the synovial tissue and of the cartilage. In the presence of Zymosan, the juxtarticular and 
periarticular tissues develop similar alterations to those found in the autoimmune diseases. 
Key word: Rheumatoid arthritis RA; induced arthritis by Zymosan AZy; anti-tumor necrosis 
 factor (TNF)-α.
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activation, initiating an inflammatory process that stim-
ulates the release of cytosine. Most of the cells can pro-
duce cytosine, but, the macrophages play a major role 
because the cytocines derived from the macrophage 
alter the behavior between the endothelial cells and 
leukocytes (TNFα ), recruitment of leukocytes (IL-8), 
reply in the acute phase (IL-6, IL-1) and immunologi-
cal function (IL-1, il-6, IL12). Interlucina-1(IL1) me-
diates the inflammatory reply in the natural immunity 
and stimulates the osseous absorption, increasing the 
precursory number of cells of osteoclasts, besides stim-
ulating the production of prostaglandins and collagens 
by the fibroblasts and osteoblasts. Interlukine-6 (IL-6). 
stimulates the proliferation of T cells, the activation of 
the natural mechanism of cellular death and cytotoxic-
ity. 
        The anti-tumor necrosis factor (TNF)-α also known 
as cachectin, is mainly produced by macrophages, but 
can also be set free for lymphocytes and mastocytes. Be-
sides inducing production of collagens and prostaglan-
dins, it is chemotactic for inflammatory cells [28]. The 
TNFα regulates the synthesis of other cytokines such as 
the IL-6 and the IL-1. Pro-inflammatory cytokines such 
as the factor of tumor necrosis (TNF) and the interleu-
kin I (IL-1) induce hyperactivity of auxiliary T cells. 
The result includes expansion of the cellular immuni-
ty and synthesis of auto-antibodies by lymphocytes B 
[27]. Occurrences such as activation of the complement 
(generated by auto-antibodies that may be deposited in 
the tissue), aggregated platelets and synthesis of pros-
taglandins culminate with intense vasculitis of small 
veins in the RA evolution process in tissues. The syn-
ovial alterations in RA are edema and accumulation of 
lymphocytes, plasmacytes and macrophages; concomi-
tantly with increase of the vascularity and exudates in 
the articular space, resulting in fibrin nodules that float 
in the joint (rice corpuscle) [4,10]. The synovial cover-
ing cells, composed of three layers, suffer hyperplasia 
and form layers with 8 to 10 cells thick that results in 
covering synovial tissues with numerous villosities. As 
the synovium suffers hyperplasia and hypertrophy, it 
is elongated on the articular cartilage and as from this 
incident known as pannus [23, 24]. Pannus produces 
erosion of the articular cartilage and of the underlying 
bone through the action of collagens produced by it that 
penetrates into the subchondral bone affecting tendons, 
ligaments and the articular capsule. When the articular 
cartilage is destroyed, it suffers fibrosis and develops 
into ankylosis [9]. Treatment of the aggressive RA cases 
is onerous for public funds, a complication that makes 
the disease particularly worrying. The immediate begin-
ning of the treatment and the precocious diagnosis are 
basic for the control of the activity of the disease and to 
prevent functional incapacity and irreversible articular 
injury [6]. In order to understand the processes that in-
volve the evolution of the autoimmune disease, so that 
they can be prevented or interrupted, a search was made 
for experimental models, to reproduce the majority of 
the findings of RA and to minutely research the evolu-
tion of the disease as well as the effects on the tissue of 
an autoimmune aggression. In order for the animal mod-
els to be accepted, they must supply information on the 
hystopathological, biomolecular and genetic aspects of 
autoimmunity. They must point out characteristics with 
clinical, pathological and radiological findings, similar 
to those of RA and with few systemic manifestations. 
The beginning, the gravity and incidence of the disease 
must be trustworthy, with reproduction of the arthri-
tis within a short period to allow for fast experimental 
protocols that are really measurable [2]. Experimental 
arthritis has been induced through substances, such as 
adjuvant, fragments of streptococcal cellular wall, type 
II collagen, retrovirus, lactobacillus, micoplasma, my-
cobacteria [16] and Zymosan (Zy) [10,13]. Zymosan is 
a polysaccharide derived from the wall of the Saccharo-
myces cerevisiae fungus that possesses in its structure 
an organosulphorous composition with immunomodu-
latory properties, the β- glucan, widely used in vivo 
experiments to study the behavior of leukocycitatic 
cells in inflammatory process [10]. Through the dec-
tin1 receiver, Zymosan is recognized for macrophages 
and interacts with the TLR2 receiver [27] that has an 
important role in the development of acquired immune 
answers [12].
 MATERIAL AND METHODS
          
           This study was approved by the CEEA-IB/
UNICAMP in 04/05/2005 under no. 811-1. In the study 
of arthritis in Wistar rats (Rattus norvegicus albinus), 
80-day old females with 250g each from the central vi-
varium of the Medical Science College of the Campi-
nas State University were divided into group, control 
and treated. The group control was submitted to intra-
articular injection of saline solution and the induced 
one (AZy) received intra-articular Zymosan in the right 
knee. The inductive vehicle used was Zymosan - Sac-
charomyces cerevisiae (Sigma, St Louis, MO, USA) 
and chloral Hydrate anesthesia at 10 %, (400mg/kg 
intraperitoneal). The AZy groups received the Zymo-
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san injection (1mg) under anesthesia, in 50µl of saline 
solution at 0.9% in the infra patellar region of the right 
knee and group C, 50µl of saline solution at 0.9%. 
The experiments were concluded at different times, 3, 
7, 14 days of arthritis induction, followed by sacrifice 
by deep anesthetic. Inflammatory signs were collected 
through articular cirtometry (edema), articular heat, 
redness and loss of function (time of nociception-paw 
rise) for inclusion of the animal in the experiment. The 
parts containing the right femur-pattelar joint were 
collected, identified, immersed in formalin solution at 
10% for 48 hours, decalcified by EDTA and after 72 
hours, they were included in paraffin. The histological 
5-micrometer cuts obtained were stained by the hema-
toxylin-eosin method and analyzed in Carl Zeiss optic 
photomicroscope in the Anatomy department. Radio-
logical images were collected using dental periapical 
radiographic films. The Accurate Fischer test was used 
for the statistical analysis of the results and the 5% sig-
nificance level was adopted. The surgical procedures 
and treatments were carried out according to The Guide 
for the Care and Use of Laboratory Animals (DHEW 




         The average values of articular temperature col-
lected on the 3rd day of arthritis induction by Zymosan 
(AZy), presented, in relation to the control, an increase 
in 24hrs after the induction of AZy, but which remained 
unchanged until the 3rd day when they gradually di-
minished until the 14th day (Table 1).
            
Table 1
Average temperature values of the groups given in cen-
tigrades.
Loss of function
After the end of the anesthesia sedation, the animals 
were stimulated to walk and the animals induced with 
intra-articular Zy, kept their paws raised for 8 hours. (8 
TEP = h - time of paw rise). 
Edema
The presence of articular tumor was observed through 
cirtometric values of the articular edema (Table 2).
Table 2 - Cirtometric Values in the groups
The cirtometric averages of the increase in value as 
from the 3rd day of arthritis induction.
 Control 24 hours  3 days 7 days 14 days
N=10 36.840 39.270 39.250 38.070 37.540
N=10




control 3 days zy 7 days zy 14 days zy
Average 5.88 6.61 7.18 7.16
Total no. = 40
Significant statistic index on the Fisher scale P-value = 
0.4552 
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The average cirtometric values of the 14th day of AZy, 
increased by 52.7% in relation to the average values of 
the control group. 
Pain
The articular pain perceived to palpation was present in 
the first 24 hours, remaining unchanged until the 14th 
day,  statistically acquiring insignificant values with 
p=0.4552 on the Fischer scale. 
Redness
Together with the edema and temperature increase, the 
joint submitted to intra-articular Zymosan injections, 
takes on moderate indexes in 24 hours to the 3rd day, 
going onto intense on the 7th day and again moderate 




Figure. 1 Comparation of roentgenogaph of normal rat knee (A) showing intra-articular line preserved, show-
ing that the distance between the osseous extremities seen in the x-ray is kept by the thickness of the articular 
cartilage present and intact, and with anatomically positioned patella score bar : 1cm. (B) group experimentally 
induced by Azy, one can observe subchcondral translucent areas with erosion in the above located patella, ad-
hered to the femoral condyle, diminishing the group experimentally induced by Azy, one can observe subch-
condral translucent areas with erosion in the above located patella, adhered to the femoral condyle. bar: 1cm.
        In the radiological analysis, the control group 
presents normal radiological aspects with intra-articu-
lar line preserved, showing that the distance between 
the osseous extremities seen in the x-ray is kept by the 
thickness of the articular cartilage present and intact, 
and with anatomically positioned patella (fig.1 A). In 
the group experimentally induced by Azy, one can ob-
serve subchcondral translucent areas with erosion in the 
above located patella, adhered to the femoral condyle, 
diminishing the space between the femur and the supra 
patellar tendon, showing compression of soft parts. (fig. 
1 B)
Histological analysis
        It was observed that in the microscopic analysis 
of the collected material on the 3rd day after the inocu-
lation with Zymosan there was a presence of moder-
ate inflammation with synovial and villous hyperpla-
sia in the juxtaposed soft tissues, producing a chronic, 
unspecified, inflammatory process (fig.2.B,C). On the 
7th day of AZy, an intra-articular region is noticed with 
infiltrated, unspecific, diffuse inflammatory lymphop-
lasmocytes with beginning of inflammatory flake or-
ganization. The great difference between the 3rd and 
7th day is that there is osseous reactionary prolifera-
tion. In the 14-day induced arthritis, aggregate-forming 
infiltrated, inflammatory focal lymphoplasmocytes are 
present. The inflammation is intense, located in the syn-
ovial, muscular, periarticular tissue. The inflammation 
focus is organized with predominance of giant cells and 
marginal erosions in the osseous tissue appear. There 
is presence of pannus and the articular surface is de-
stroyed with reactive neoformed osseous tissue (fig. 2 
D,E).
DISCUSSION
        Animal models of arthritis have been used so that 
the elements that participate in the arthritic process and 
its mechanisms of action in the biological structures of 
the patients are understood [16]. The development of 
new drugs [5] or physical kinds of treatment find pow-
erful tools to study pathological changes in biologi-
cal tissues, systems and organs in the animal models 
[16,17-30]. Although the articular inflammation points 
out its presence with more destruction, the reversal of 
the inflammatory and erosive process can also be seen 
through the different mediators involved in these pro-
cesses [3,7,8-12]. When choosing a model of experi-
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Figure .2 Histological section of knee joint change: (A) normal knee joint of an 
unijected rat showing condyles laterally (*) and subsynovial areolar tissue above 
(è). Hematoxylin and eosin, score bar 10 µm. (B) Zymosan –induced arthritis in 
a kenee join 3 days postinjection showing synovial lining hyperplasia (¨) and low 
score for cellular infiltration. Hematoxylin and eosin score bar 5µm. (C) Zymosan 
induced arthrits after 7 days postinjection showing subsynovial and periarticular 
tissue contained a moderate infiltration infiltrate histiocystes with patchy areas of 
PMN aggregation (Ù).(è). Hematoxylin and eosin score bar 5µm. (D) Zymosan- 
induced 14 days after injection in knee joint changes of synovial hypertrophy and 
pannus. The inflammation focus is organized with predominance of giant cells 
granuloma (è). Hematoxylin and eosin score bar 5µm. (E) Detail of granuloma in 
synovia (æ). Hematoxylin and eosin score bar 2,5µm
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mental arthritis, it was necessary to choose a functional 
model, of easy reproducibility, fast induction and that 
would not be burdensome. Analyzing these premises 
[5, 11], the choice was for a model of induced arthritis 
that would use wisar rats, due to their easy acquisition 
and handling [2, 31]. In the search for an ideal inductive 
agent, after some pilots, it was confirmed that Zymo-
san produced the inflammation that was pertinent to the 
contents of this study. The developed biological altera-
tions should allow the accompaniment both in the acute 
and the chronic phases [17]. The first evidences of the 
inflammatory signals were proved when 48 hours after 
intra-articular induction by Zymosan, there was loss of 
function, observed through the time of paw raise (TEP) 
that was maximum for 8 hours after the incident [25]. 
The inflammatory process continued its evolution after 
chronicity of the inflammatory process was observed 
on the 14th day [22]. Mastocytes are degraded [4, 16] 
and increase the cellular permeability [8], taking an ex-
perimental model to the inflammation after being sub-
mitted to intra-articular injections by Zymosan [12,3]. 
In 1994 it was proved that 2mg Zymosan intra-articular 
injection produces acute inflammation and periarticular 
intra-articular on day zero, followed by sub-acute ero-
sive synovitis [13]. 
        Using (30) rats submitted to experimental arthri-
tis induced by collagen, proved the harmful effect of 
TNF - and IL-1α in the synovial tissue and the cartilage, 
reduced in intensity after use of IL-4, and suggested re-
search aiming at the use of this cytokine as a potential 
chondroprotective therapy [12, 23, 24-32]. 
       In the injury of the cartilage by Zymosan, there 
are hystopathological, hystochemical and biochemi-
cal characteristics that are applied to the experimental 
study of RA and that, partly, meet the minimum re-
quirements considered by Oliver and Brahn (1996) for 
the study of the human disease in animal models. In this 
experimental study, the arthritis induced by Zymosan, 
uses, as parameter, the cellular migration, radiologi-
cal images and the inflammatory signals. During the 
induction process, after inoculation with Zymosan, on 
the 3rd day we found: moderate inflammation, synovial 
and villous hyperplasia, unspecific chronic inflamma-
tory process [17, 18], soft juxtaposed tissues or para-
articular with unspecific inflammation with some rich 
PMN in neutrophils. As the synovium is approached, 
the amount of neutrophil diminishes [27]. In osseous 
cork l, the periosteum appears swollen. Predominance 
of broken up neutrophil [2, 14]. On the 7th day after 
inoculation, we noticed infiltrated inflammatory unspe-
cific diffuse lymphoplasmocytosis with intense inflam-
mation, beginning of inflammatory flake organization. 
Inflammation rich in neutrophil. Inflammatory process, 
soft tissue parts articular joust and synovium [26] In-
tra and peri-articular inflammation, presence of giant 
cells. Inflammation 2 and 3 degree. On the 14th day 
after inoculation, we found infiltrated inflammatory fo-
cal lymphoplasmocytosis forming aggregate. Adipose 
peri-articular tissues. Villous hyperplasia. Degree 3 
intense inflammation localized in the synovial, mus-
cular, peri-articular tissue. Inflammation focus orga-
nized with predominance of giant cells. Appearance of 
marginal erosions [31, 32] in the osseous tissue. Pres-
ence of pannus. Lymphocytic inflammation, productive 
granuloma, non- caseous, ample and rose cytoplasm of 
Langhans cells. Epithelioid cells. Presence of giant cell 
granuloma [8].
      Cellular giant reaction with granuloma of strange 
body with intense necrosis area. articular destroyed 
surface exposing the reactive neoform osseous tissue 
[13, 14, 15, 17, 18, 26-3].
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